Article: ADVANCED INTERVENTIONAL SYSTEMS ADDS NEW CATHETER TO CLINICAL TRIALS WITH EXCIMER LASER SYSTEM

 
   ADVANCED INTERVENTIONAL SYSTEMS ADDS NEW CATHETER 
 TO CLINICAL TRIALS WITH EXCIMER LASER SYSTEM 
Directional Catheter Selectively Targets Plaque 
   in Coronary Arteries 
IRVINE, Calif., Jan. 16 /PRNewswire/ -- The federal Food and Drug Administration (FDA) has approved a new directional catheter designed by Advanced Interventional Systems (NASDAQ: LAIS) for use as an investigational device in the company's clinical trials to treat coronary disease, the company announced today. 
According to Advanced Interventional Systems' chief executive officer, Robert E. Wall, the innovative and distinguishing feature of the company's new catheter ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!